Results 181 to 190 of about 3,286,390 (370)
Thoracic Surgery Committee on Adjuvant Therapy of Non-small Cell Lung Cancer
doaj +1 more source
A mathematical model of CAR-T cell therapy in combination with chemotherapy for malignant gliomas [PDF]
We study the dynamics and interactions between combined chemotherapy and chimeric antigen receptor (CAR-T) cells therapy and malignant gliomas (MG). MG is one of the most common primary brain tumor, with high resistance to therapy and unfavorable prognosis.
arxiv
Red cell aplasia following prolonged D-penicillamine therapy. [PDF]
John L. Gollan+3 more
openalex +1 more source
The authors applied joint/mixed models that predict mortality of trifluridine/tipiracil‐treated metastatic colorectal cancer patients based on circulating tumor DNA (ctDNA) trajectories. Patients at high risk of death could be spared aggressive therapy with the prospect of a higher quality of life in their remaining lifetime, whereas patients with a ...
Matthias Unseld+7 more
wiley +1 more source
MiR‐99a‐5p/miR‐100‐5p (functionally identical) and miR‐125b‐5p microRNAs are downregulated in malignant germ cell tumors (GCTs). Combination replenishment of these microRNAs using mimics resulted in growth inhibition in representative cell lines, with consequent downregulation of target genes involved in cell cycle (confirmed by flow cytometry) and ...
Marta Ferraresso+12 more
wiley +1 more source
Simulating cell populations with explicit cell cycle length -- implications to cell cycle dependent tumour therapy [PDF]
In this study, we present a stochastic simulation model designed to explicitly incorporate cell cycle length, overcoming limitations associated with classical compartmental models. Our approach employs a delay mechanism to represent the cell cycle, allowing the use of arbitrary distributions for cell cycle lengths. We demonstrate the feasibility of our
arxiv
A Case of Red Cell Aplasia Occurring as a Result of Antituberculous Therapy
Stephen B. Goodman, Matthew Block
openalex +1 more source
Cell Cycle Kinetics and Radiation Therapy [PDF]
Mortimer L. Mendelsohn
openalex +1 more source
We assessed the associations between the gut microbiota and outcome in metastatic triple‐negative breast cancer patients treated with chemotherapy alone or chemotherapy in combination with immunotherapy. Our data indicate that high gut microbiota alpha diversity was associated with improved clinical outcome and with benefit from immunotherapy.
Andreas Ullern+8 more
wiley +1 more source